A Phase 2, Investigator-Initiated, Randomized, Double-blind, Placebo-controlled Pilot Study to Evaluate the Safety and Efficacy of RM-131 Administered to Females With Anorexia Nervosa

Trial Profile

A Phase 2, Investigator-Initiated, Randomized, Double-blind, Placebo-controlled Pilot Study to Evaluate the Safety and Efficacy of RM-131 Administered to Females With Anorexia Nervosa

Completed
Phase of Trial: Phase II

Latest Information Update: 30 Sep 2016

At a glance

  • Drugs Relamorelin (Primary)
  • Indications Anorexia nervosa; Gastrointestinal disorders
  • Focus Proof of concept; Therapeutic Use
  • Sponsors Rhythm; Rhythm Pharmaceuticals
  • Most Recent Events

    • 04 Apr 2016 According to a Motus media release, the results of this trial were presented at the ENDO2016 conference.
    • 04 Apr 2016 Results published in a Motus media release.
    • 14 Oct 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top